mSToPS: How Digital Wearables Could Enable Less Costly, More Real-World Clinical Trials - A Conversation with Steven Steinhubl, MD

article image

As medtech stakeholders debate the best ways to design and implement more cost effective, pragmatic, and patient-centric clinical trials, one recent digital health study that remotely screened high-risk individuals for undiagnosed atrial fibrillation could help provide a roadmap for the future.

The mHealth Screening to Prevent Strokes (mSToPS) trial is one of the first large, randomized screening trials conducted entirely remotely using a digital wearable deviceā€”in this case an ECG monitoring patch.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: